Detalhe da pesquisa
1.
Loss of Kmt2c in vivo leads to EMT, mitochondrial dysfunction and improved response to lapatinib in breast cancer.
Cell Mol Life Sci
; 80(4): 100, 2023 Mar 18.
Artigo
Inglês
| MEDLINE | ID: mdl-36933062
2.
Evaluation of the Small Heat Shock Protein Family Members HSPB2 and HSPB3 in Bladder Cancer Prognosis and Progression.
Int J Mol Sci
; 24(3)2023 Jan 30.
Artigo
Inglês
| MEDLINE | ID: mdl-36768927
3.
SARS-CoV-2 humoral responses following booster BNT162b2 vaccination in patients with B-cell malignancies.
Am J Hematol
; 97(10): 1300-1308, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35871310
4.
High mRNA Expression Levels of Heat Shock Protein Family B Member 2 (HSPB2) Are Associated with Breast Cancer Patients' Relapse and Poor Survival.
Int J Mol Sci
; 23(17)2022 Aug 28.
Artigo
Inglês
| MEDLINE | ID: mdl-36077156
5.
Isolation of an Extract from the Soft Coral Symbiotic Microorganism Salinispora arenicola Exerting Cytoprotective and Anti-Aging Effects.
Curr Issues Mol Biol
; 44(1): 14-30, 2021 Dec 22.
Artigo
Inglês
| MEDLINE | ID: mdl-35723381
6.
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients.
BMC Med
; 19(1): 208, 2021 08 23.
Artigo
Inglês
| MEDLINE | ID: mdl-34420521
7.
Heat shock protein beta 3 (HSPB3) is an unfavorable molecular biomarker in colorectal adenocarcinoma.
Mol Carcinog
; 59(1): 116-125, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31709619
8.
Non-lethal proteasome inhibition activates pro-tumorigenic pathways in multiple myeloma cells.
J Cell Mol Med
; 23(12): 8010-8018, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31568628
9.
Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose.
Blood
; 137(26): 3674-3676, 2021 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33861315
10.
Phytochemical Composition of the Decoctions of Greek Edible Greens (Chórta) and Evaluation of Antioxidant and Cytotoxic Properties.
Molecules
; 23(7)2018 06 26.
Artigo
Inglês
| MEDLINE | ID: mdl-29949914
11.
Third dose of the BNT162b2 vaccine results in very high levels of neutralizing antibodies against SARS-CoV-2: Results of a prospective study in 150 health professionals in Greece.
Am J Hematol
; 97(4): E147-E150, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35025124
12.
Age-dependent and gender-dependent antibody responses against SARS-CoV-2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine.
Am J Hematol
; 96(7): E257-E259, 2021 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33837984
13.
Comparison of neutralizing antibody responses against SARS-CoV-2 in healthy volunteers who received the BNT162b2 mRNA or the AZD1222 vaccine: Should the second AZD1222 vaccine dose be given earlier?
Am J Hematol
; 96(9): E321-E324, 2021 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34028867
14.
Patients with type 2 diabetes mellitus present similar immunological response to COVID-19 BNT162b2 mRNA vaccine to healthy subjects: a prospective cohort study.
Hormones (Athens)
; 22(1): 5-11, 2023 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-36269544
15.
Longitudinal Analysis of Antibody Response Following SARS-CoV-2 Infection Depending on Disease Severity: A Prospective Cohort Study.
Viruses
; 15(11)2023 Nov 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38005927
16.
SARS-CoV-2 Neutralizing Antibodies Kinetics Postvaccination in Cancer Patients under Treatment with Immune Checkpoint Inhibition.
Cancers (Basel)
; 14(11)2022 Jun 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35681774
17.
Low neutralizing antibody responses in WM, CLL and NHL patients after the first dose of the BNT162b2 and AZD1222 vaccine.
Clin Exp Med
; 22(2): 319-323, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-34283338
18.
Determination of MYD88L265P mutation fraction in IgM monoclonal gammopathies.
Blood Adv
; 6(1): 189-199, 2022 01 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34788399
19.
Autophagy activation can partially rescue proteasome dysfunction-mediated cardiac toxicity.
Aging Cell
; 21(11): e13715, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36259256
20.
Assessment of Postvaccination Neutralizing Antibodies Response against SARS-CoV-2 in Cancer Patients under Treatment with Targeted Agents.
Vaccines (Basel)
; 10(9)2022 Sep 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36146552